首页 | 本学科首页   官方微博 | 高级检索  
   检索      

雷帕霉素对小鼠葡萄糖代谢水平的影响
引用本文:周迎生,王丽娟,刘波,颜迪恩,张福庄,袁仙仙.雷帕霉素对小鼠葡萄糖代谢水平的影响[J].中国实验动物学报,2012(6):1-4,96.
作者姓名:周迎生  王丽娟  刘波  颜迪恩  张福庄  袁仙仙
作者单位:首都医科大学附属北京安贞医院内分泌科;北京市心肺血管疾病研究所;卫生部北京医院;首都医科大学附属北京友谊医院
基金项目:国家自然科学基金项目(项目批准号81041024);教育部留学回国人员科研启动基金[(2012)940];人事部留学回国人员科研启动基金[(2010)412]
摘    要:目的探讨雷帕霉素对葡萄糖代谢水平影响的特点、机制。方法选择4周龄、雄性C57BL/6小鼠,高热量、高脂饮食喂养8周后为肥胖组(HF,n=18),普通饲料喂养为正常组(NC,n=18)。两组小鼠分别给予安慰剂(n=6)、腹腔注射雷帕霉素(2 mg/kg,隔日1次,n=6)、喂饮2.37%亮氨酸水(n=6),2周后分别行灌胃葡萄糖耐量试验(glucose tolerance test,GTT)、胰岛素耐受性试验(insulin tolerance test,ITT)以及胰岛组织病理学检查。结果正常组小鼠腹腔注射雷帕霉素后葡萄糖负荷30min血糖水平显著升高(与安慰剂组比P=0.038,与亮氨酸组比P=0.035)。肥胖组小鼠腹腔注射雷帕霉素后空腹血糖水平显著高于安慰剂组(P=0.031),葡萄糖负荷30 min血糖显著高于安慰剂组(P=0.013)、亮氨酸组(P=0.041)。仅正常组小鼠胰岛素敏感性与安慰剂组相比显著降低(P=0.039)。雷帕霉素干预后腹腔脂肪量显著减少(正常组与安慰剂组比P0.001,肥胖组与安慰剂组比P=0.013)。结论雷帕霉素对哺乳动物糖代谢水平有显著影响,正常小鼠与机体胰岛素敏感性下降有关;肥胖小鼠与胰岛素分泌功能受损、胰岛素抵抗相关。

关 键 词:雷帕霉素  血糖  胰岛素抵抗

Effects of rapamycin on glucose metabolism and insulin resistance in obese mice
ZHOU Ying-sheng,WANG Li-juan,LIU Bo,YAN Di-en,ZHANG Fu-zhuang,YUAN Xian-xian.Effects of rapamycin on glucose metabolism and insulin resistance in obese mice[J].Acta Laboratorium Animalis Scientia Sinica,2012(6):1-4,96.
Authors:ZHOU Ying-sheng  WANG Li-juan  LIU Bo  YAN Di-en  ZHANG Fu-zhuang  YUAN Xian-xian
Institution:1(1.Department of Endocrinology & Metabolism,Capital Medical University affiliated Beijing Anzhen Hospital, Beijing Institute of Heart,Lung and Vascular Diseases,Beijing 100029,China;2.Beijing Hospital,Beijing 100730; 3.Beijing Friendship Hospital,Capital Medical University,Beijing 100050)
Abstract:Objective To explore the effects of rapamycin on blood glucose level and insulin resistance in diet-in- duced obese mice. Methods Healthy 4 week-old male C57BL/6 mice were fed with high fat diet ( HF, n = 18 ) or nor- mal chow (normal control, NC, n = 18) for 8 weeks. Both control and obese mice were treated with placebo, rapamycin 2 mg/kg,intraperitonealy (ip) , Qod, n = 6 ] and 2.37% leucine-containing drinking water ( n = 6) for 2 weeks, respec- tively. Oral glucose tolerance test (OGTT) , insulin tolerance test (ITT) and morphological studies for pancreatic islets were performed. Results The normal mice treated with rapamycin showed a significant increase of glucose level at 30 mi- nutes after glucose challenge in comparison with the placebo- (P = 0. 038) and leucine-treated (P = 0. 035) groups. The rapamycin-treated obese mice showed a significantly elevated fasting glucose level compared with the placebo-treated obese mice (P = 0. 031 ), and a higher glucose level at 30 minutes after glucose challenge than that in the placebo-treated mice (P =0. 013) and leucine-treated mice (P =0. 041 ). The normal mice after rapamycin treatment had a decreased insulin sensitivity than those with placebo treatment (P = 0. 039). Rapamycin treatment significantly reduced the peritoneal whiteadipose mass in both normal (P 〈 O. 001 ) and obese mice (P = 0. 013) than in the placebo controls. Conclusions Rapa- mycin had significant effect on glucose metabolism in mice. The impairment of glucose metabolism in normal mice after ra- pamyein treatment is correlated with decreased glucose tolerance, while the impairment of glucose metabolism in obese mice is resulted from reduced insulin secretion and increased insulin resistance.
Keywords:Rapamycin  Blood glucose  Insulin resistance
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号